TheFly.com
HUMA
Humacyte
$
()
Humacyte management to meet with BTIG
Humacyte management to meet with BTIG
Humacyte management to meet with BTIG
Humacyte reports Q4 EPS (24c), consensus (24c)
Humacyte price target raised by $1 at Piper Sandler, here's why
Humacyte 13.4M share Spot Secondary priced at $3.00
Humacyte announces common stock offering, no amount given
Humacyte announces U.S. FDA accepted, granted priority review to BLA of HAV
Humacyte price target lowered by $1 at Benchmark, here's why
Humacyte submits BLA to U.S. FDA seeking approval of HAV
Humacyte initiated with bullish view at H.C. Wainwright, here's why
Copyright ©1998-2024 Thefly.com LLC
